膀蒄膃吲哚布芬对急性脑梗死治疗的临床分析芄蒂芀杨琨孙佳凡蚈薇膁山西省中西医结合医院神经内科莃虿罿ClinicAnalysisofTreatmentontheAcuteIschemicStrokewithIndobufen莀芆芆Yang-kunSun-jiafan莃肀莀DepartmentofNeurology,ShanxiProvincialHospitalofIntegratedTraditionalChineseandWesternMedicine,Taiyuan030013,China;螈肅莈〔Abstract〕ObjectiveToinvestigatetheeffectsandsafetyofXinbei-(n=82)andcontrolgroup(n=88).Thepatientsinexperimentgroupweregivenanti-plateletindobufen(200mg,bid)andothersincontrolgroupweregivenaspirin(100mg,qd),:Aftertreatment,theplateletaggregationinbothgroupswerelowerat2-weekand6-weeksthanbefore(P<).Thescoreofneurologyimpairmentinthebothgroupswereimprovedatthe6-weeks(P<).Therewasnosignificantdifferenceintheplateletaggregationandthescorebetweenexperimentgroupandcontrolgroup(P>).-:Indobufen,anti-platelet,acuteischemicstroke蒀肈羅摘要:目的探讨吲哚布芬治疗急性脑梗死患者的临床疗效。方法入选的170例急性脑梗死患者随机分为试验组(n=82)和阳性药物对照组(n=88),试验组给予吲哚布芬治疗
吲哚布芬对急性脑梗死治疗临床研究 来自淘豆网m.daumloan.com转载请标明出处.
